Medpace Holdings Pre-Tax Income 2014-2024 | MEDP

Medpace Holdings annual/quarterly pre-tax income history and growth rate from 2014 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Medpace Holdings pre-tax income for the quarter ending September 30, 2024 was $0.119B, a 42.76% increase year-over-year.
  • Medpace Holdings pre-tax income for the twelve months ending September 30, 2024 was $0.433B, a 35.82% increase year-over-year.
  • Medpace Holdings annual pre-tax income for 2023 was $0.336B, a 18.67% increase from 2022.
  • Medpace Holdings annual pre-tax income for 2022 was $0.283B, a 40.13% increase from 2021.
  • Medpace Holdings annual pre-tax income for 2021 was $0.202B, a 19.77% increase from 2020.
Medpace Holdings Annual Pre-Tax Income
(Millions of US $)
2023 $336
2022 $283
2021 $202
2020 $169
2019 $125
2018 $94
2017 $57
2016 $22
2015 $-8
2014 $-21
2013 $39
Medpace Holdings Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $119
2024-06-30 $110
2024-03-31 $113
2023-12-31 $91
2023-09-30 $83
2023-06-30 $76
2023-03-31 $86
2022-12-31 $74
2022-09-30 $82
2022-06-30 $62
2022-03-31 $65
2021-12-31 $56
2021-09-30 $55
2021-06-30 $43
2021-03-31 $49
2020-12-31 $55
2020-09-30 $47
2020-06-30 $30
2020-03-31 $36
2019-12-31 $36
2019-09-30 $29
2019-06-30 $34
2019-03-31 $25
2018-12-31 $29
2018-09-30 $25
2018-06-30 $22
2018-03-31 $18
2017-12-31 $14
2017-09-30 $15
2017-06-30 $14
2017-03-31 $14
2016-12-31 $0
2016-09-30 $8
2016-06-30 $8
2016-03-31 $6
2015-12-31
2015-09-30 $1
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.789B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00